Brain Functional effects of psychopharmacological treatment in major depression: A focus on neural circuitry of affective Processing

Current Neuropharmacology

Volumn 13, Issue 4, 2015, Pages 466-479

  Wessa, Michèle ^a   Lois, Giannis ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antidepressants; Brain activity; Major depression

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; MIRTAZAPINE; NORADRENALIN; PAROXETINE; REBOXETINE; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ANTERIOR CINGULATE; ARTICLE; BECK DEPRESSION INVENTORY; BRAIN DEPTH STIMULATION; BRAIN MALFORMATION; COGNITIVE THERAPY; DEFAULT MODE NETWORK; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NERVE POTENTIAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TASK POSITIVE NETWORK; ANIMAL; BRAIN; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; EMOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84942123818     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X13666150416224801     Document Type: Article

References (62)

1. Groenewold, N.A.; Opmeer, E.M.; de Jonge, P.; Aleman, A.; Costafreda, S.G. Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neurosci. Biobehav. Rev., 2013, 37, 152-63. http:// dx.doi.org/10.1016/j.neubiorev.2012.11.015
2. Hamilton, J.P.; Etkin, A.; Furman, D.J.; Lemus, M.G.; Johnson, R.F.; Gotlib, I.H. Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data. Am. J. Psychiatr., 2012, 169, 693-703. http://dx.doi.org/10.1176/appi.ajp.2012.11071105
3. Harmer, C.J.; Goodwin, G.M.; Cowen, P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br. J. Psychiat., 2009, 195, 102-8. http://dx.doi.org/10.1176/appi.ajp.2012.11071105
4. Roiser, J.P.; Elliott, R.; Sahakian, B.J. Cognitive mechanisms of treatment in depression. Neuropsychopharmacol., 2012, 37, 117-36. http://dx.doi.org/10.1038/npp.2011.183
5. Diener, C.; Kuehner, C.; Brusniak, W.; Ubl, B.; Wessa, M.; Flor, H. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage, 2012, 61, 677-85. http://dx.doi.org/10.1016/j.neuroimage.2012.04.005
6. Anderson, I.M.; Del-Ben, C.M.; McKie, S.; Richardson, P.; Williams, S.R.; Elliott, R.; Deakin, J.F. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport, 2007, 18, 1351-5. http://dx.doi.org/10.1097/ WNR.0b013e3282742115
7. Arce, E.; Simmons, A.N.; Lovero, K.L.; Stein, M.B.; Paulus, M.P. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology, 2008, 196, 661-72. http://dx.doi.org/10.1007/s00213-007-1004-8
8. Del-Ben, C.M.; Deakin, J.F.; McKie, S.; Delvai, N.A.; Williams, S.R.; Elliott, R.; Dolan, M.; Anderson, I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacol., 2005, 30, 1724-34. http://dx.doi.org/10.1038/sj.npp.1300728
9. Harmer, C.J.; Mackay, C.E.; Reid, C.B.; Cowen, P.J.; Goodwin, G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol. Psychiat., 2006, 59, 816-20. http://dx.doi.org/10.1016/j.biopsych.2005.10.015
10. Murphy, S.E.; Norbury, R.; O'Sullivan, U.; Cowen, P.J.; Harmer, C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. Brit. J. Psychiat., 2009, 194, 535-40. http://dx.doi. org/10.1192/bjp.bp.108.056093
11. Takahashi, H.; Yahata, N.; Koeda, M.; Takano, A.; Asai, K.; Suhara, T.; Okubo, Y. Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. Neuroimage, 2005, 27, 991-1001. http://dx.doi.org/10.1016/ j.neuroimage.2005.05.039
12. Windischberger, C.; Lanzenberger, R.; Holik, A.; Spindelegger, C.; Stein, P.; Moser, U.; Gerstl, F.; Fink, M.; Moser, E.; Kasper, S. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage, 2010, 49, 1161-70. http://dx.doi.org/10.1016/j.neuroimage.2009.10.013
13. Norbury, R.; Taylor, M.J.; Selvaraj, S.; Murphy, S.E.; Harmer, C.J.; Cowen, P.J. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology, 2009, 206, 197-204. http://dx.doi.org/10.1007/s00213-009-1597-1
14. Kraus, C.; Ganger, S.; Losak, J.; Hahn, A.; Savli, M.; Kranz, G.S.; Baldinger, P.; Windischberger, C.; Kasper, S.; Lanzenberger, R. Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake. Neuroimage, 2014, 84, 236-44. http://dx.doi.org/10.1016/ j.neuroimage.2013.08.036
15. van Wingen, G.A.; Tendolkar, I.; Urner, M.; van Marle, H.J.; Denys, D.; Verkes, R.J.; Fernandez, G. Short-term antidepressant administration reduces default mode and task-positive network connectivity in healthy individuals during rest. Neuroimage, 2013, 88C, 47-53.
16. Hamilton, J.P.; Furman, D.J.; Chang, C.; Thomason, M.E.; Dennis, E.; Gotlib, I.H. Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol. Psychiat., 2011, 70, 327-33. http://dx.doi.org/10.1016/j.biopsych.2011.02.003
17. Norbury, R.; Mackay, C.E.; Cowen, P.J.; Goodwin, G.M.; Harmer, C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br. J. Psychiat., 2007, 190, 531-2. http://dx.doi.org/10.1192/bjp.bp.106.031393
18. Miskowiak, K.; Papadatou-Pastou, M.; Cowen, P.J.; Goodwin, G.M.; Norbury, R.; Harmer, C.J. Single dose antidepressant administration modulates the neural processing of self-referent personality trait words. Neuroimage, 2007, 37, 904-11. http://dx. doi.org/10.1016/j.neuroimage.2007.05.036
19. Norbury, R.; Mackay, C.E.; Cowen, P.J.; Goodwin, G.M.; Harmer, C.J. The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study. Mol. Psychiatr., 2008, 13, 1011-20. http://dx.doi.org/10.1038/sj.mp.4002091
20. Papadatou-Pastou, M.; Miskowiak, K.W.; Williams, J.M.; Harmer, C.J.; Reinecke, A. Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study. Exp. Clin. Psychopharmacol., 2012, 20, 364-72. http://dx.doi.org/10.1037/a0027969
21. McCabe, C.; Mishor, Z.; Cowen, P.J.; Harmer, C.J. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol. Psychiat., 2010, 67, 439-45. http://dx.doi.org/10.1016/j.biopsych.2009.11.001
22. Anand, A.; Li, Y.; Wang, Y.; Gardner, K.; Lowe, M.J. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. J. Neuropsych. Clin. N., 2007, 19, 274-82. http://dx.doi.org/10.1176/jnp.2007.19.3.274
23. Anand, A.; Li, Y.; Wang, Y.; Wu, J.; Gao, S.; Bukhari, L.; Mathews, V.P.; Kalnin, A.; Lowe, M.J. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacol., 2005, 30, 1334-44. http://dx.doi.org/ 10.1038/sj.npp.1300725
24. Arnone, D.; McKie, S.; Elliott, R.; Thomas, E.J.; Downey, D.; Juhasz, G.; Williams, S.R.; Deakin, J.F.; Anderson, I.M. Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment. Am. J. Psychiatr., 2012, 169, 841-50. http://dx.doi.org/10.1176/ appi.ajp.2012.11121774
25. Benedetti, F.; Radaelli, D.; Bernasconi, A.; Dallaspezia, S.; Colombo, C.; Smeraldi, E. Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy. Arch. Ital. Biol., 2009, 147, 83-93.
26. Chen, C.H.; Suckling, J.; Ooi, C.; Fu, C.H.; Williams, S.C.; Walsh, N.D.; Mitterschiffthaler, M.T.; Pich, E.M.; Bullmore, E. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacol., 2008, 33, 1909-18. http://dx.doi.org/10.1038/sj.npp.1301593
27. Davidson, R.J.; Irwin, W.; Anderle, M.J.; Kalin, N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatr., 2003, 160, 64-75. http://dx.doi.org/ 10.1176/appi.ajp.160.1.64
28. Fales, C.L.; Barch, D.M.; Rundle, M.M.; Mintun, M.A.; Mathews, J.; Snyder, A.Z.; Sheline, Y.I. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. J. Affect. Disord., 2009, 112, 206-11. http://dx.doi.org/10.1016/j.jad.2008.04.027
29. Fu, C.H.; Williams, S.C.; Brammer, M.J.; Suckling, J.; Kim, J.; Cleare, A.J.; Walsh, N.D.; Mitterschiffthaler, M.T.; Andrew, C.M.; Pich, E.M.; Bullmore, E.T. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am. J. Psychiatr., 2007, 164, 599-607. http://dx.doi.org/ 10.1176/appi.ajp.164.4.599
30. Fu, C.H.; Williams, S.C.; Cleare, A.J.; Brammer, M.J.; Walsh, N.D.; Kim, J.; Andrew, C.M.; Pich, E.M.; Williams, P.M.; Reed, L.J.; Mitterschiffthaler, M.T.; Suckling, J.; Bullmore, E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiat., 2004, 61, 877-89. http://dx.doi.org/10.1001/archpsyc.61.9.877
31. Godlewska, B.R.; Norbury, R.; Selvaraj, S.; Cowen, P.J.; Harmer, C.J. Short-term SSRI treatment normalises amygdala hype http://dx.doi.org/10.1017/S0033291712000591ractivity in depressed patients. Psychol. Med., 2012, 42, 2609-17.
32. Heller, A.S.; Johnstone, T.; Light, S.N.; Peterson, M.J.; Kolden, G.G.; Kalin, N.H.; Davidson, R.J. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am. J. Psychiatr., 2013, 170, 197-206. http://dx.doi.org/10.1176/appi.ajp. 2012.12010014
33. Keedwell, P.; Drapier, D.; Surguladze, S.; Giampietro, V.; Brammer, M.; Phillips, M. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J. Psychopharmacol., 2009, 23, 775-88. http://dx.doi.org/10.1177/ 0269881108093589
34. Lemogne, C.; Mayberg, H.; Bergouignan, L.; Volle, E.; Delaveau, P.; Lehericy, S.; Allilaire, J.F.; Fossati, P. Self-referential processing and the prefrontal cortex over the course of depression: a pilot study. J. Affect. Disord., 2010, 124, 196-201. http://dx.doi. org/10.1016/j.jad.2009.11.003
35. Lisiecka, D.; Meisenzahl, E.; Scheuerecker, J.; Schoepf, V.; Whitty, P.; Chaney, A.; Moeller, H.J.; Wiesmann, M.; Frodl, T. Neural correlates of treatment outcome in major depression. Int. J. Neuropsychoph., 2011, 14, 521-34. http://dx.doi.org/10.1017/ S1461145710001513
36. Lopez-Sola, M.; Pujol, J.; Hernandez-Ribas, R.; Harrison, B.J.; Contreras-Rodriguez, O.; Soriano-Mas, C.; Deus, J.; Ortiz, H.; Menchon, J.M.; Vallejo, J.; Cardoner, N. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. Neuropsychopharmacol., 2010, 35, 2305-17. http://dx.doi.org/10.1038/npp.2010.108
37. Miller, J.M.; Schneck, N.; Siegle, G.J.; Chen, Y.; Ogden, R.T.; Kikuchi, T.; Oquendo, M.A.; Mann, J.J.; Parsey, R.V. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study. Psychiat. Res., 2013, 214, 296-305. http://dx.doi.org/10.1016/j.pscychresns.2013.08.001
38. Rizvi, S.J.; Salomons, T.V.; Konarski, J.Z.; Downar, J.; Giacobbe, P.; McIntyre, R.S.; Kennedy, S.H. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. J. Affect. Disord., 2013, 151, 573-81. http://dx.doi.org/10.1016/j.jad.2013.06.050
39. Robertson, B.; Wang, L.; Diaz, M.T.; Aiello, M.; Gersing, K.; Beyer, J.; Mukundan, S., Jr.; McCarthy, G.; Doraiswamy, P.M. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. J. Clin. Psychiat., 2007, 68, 261-7. http://dx.doi.org/10.4088/JCP.v68n0212
40. Rosenblau, G.; Sterzer, P.; Stoy, M.; Park, S.; Friedel, E.; Heinz, A.; Pilhatsch, M.; Bauer, M.; Strohle, A. Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy. J. Psychopharmacol., 2012, 26, 1424-33. http://dx.doi.org/10.1177/0269881112450779
41. Ruhe, H.G.; Booij, J.; Veltman, D.J.; Michel, M.C.; Schene, A.H. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J. Clin. Psychiat., 2012, 73, 451-9. http://dx.doi.org/10.4088/JCP.10m06584
42. Samson, A.C.; Meisenzahl, E.; Scheuerecker, J.; Rose, E.; Schoepf, V.; Wiesmann, M.; Frodl, T. Brain activation predicts treatment improvement in patients with major depressive disorder. J. Psychiat. Res., 2011, 45, 1214-22. http://dx.doi.org/10.1016/ j.jpsychires.2011.03.009
43. Schaefer, H.S.; Putnam, K.M.; Benca, R.M.; Davidson, R.J. Eventrelated functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre-and post-treatment depression. Biol. Psychiat., 2006, 60, 974-86. http://dx.doi.org/ 10.1016/j.biopsych.2006.03.024
44. Sheline, Y.I.; Barch, D.M.; Donnelly, J.M.; Ollinger, J.M.; Snyder, A.Z.; Mintun, M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiat., 2001, 50, 651-8. http://dx.doi.org/10.1016/S0006-3223(01)01263-X
45. Stoy, M.; Schlagenhauf, F.; Sterzer, P.; Bermpohl, F.; Hagele, C.; Suchotzki, K.; Schmack, K.; Wrase, J.; Ricken, R.; Knutson, B.; Adli, M.; Bauer, M.; Heinz, A.; Strohle, A. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J. Psychopharmacol., 2012, 26, 677-88. http://dx.doi.org/10.1177/ 0269881111416686
46. Tao, R.; Calley, C.S.; Hart, J.; Mayes, T.L.; Nakonezny, P.A.; Lu, H.; Kennard, B.D.; Tamminga, C.A.; Emslie, G.J. Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. Am. J. Psychiatr., 2012, 169, 381-8. http://dx.doi.org/ 10.1176/appi.ajp.2011.11040615
47. Victor, T.A.; Furey, M.L.; Fromm, S.J.; Ohman, A.; Drevets, W.C. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. Int. J. Neuropsychoph., 2013, 16, 2195-208. http://dx.doi. org/10.1017/S146114571300062X
48. Wagner, G.; Koch, K.; Schachtzabel, C.; Sobanski, T.; Reichenbach, J.R.; Sauer, H.; Schlosser, R.G. Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J. Psychiat. Neurosci., 2010, 35, 247-57. http://dx.doi.org/10.1503/jpn.090081
49. Walsh, N.D.; Williams, S.C.; Brammer, M.J.; Bullmore, E.T.; Kim, J.; Suckling, J.; Mitterschiffthaler, M.T.; Cleare, A.J.; Pich, E.M.; Mehta, M.A.; Fu, C.H. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol. Psychiat., 2007, 62, 1236-43. http://dx.doi.org/10.1016/j.biopsych.2006.12.022
50. Wang, L.; Li, K.; Zhang, Q.; Zeng, Y.; Dai, W.; Su, Y.; Wang, G.; Tan, Y.; Jin, Z.; Yu, X.; Si, T. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging. Psychol. Med., 2014, 44, 1417-26. http://dx.doi.org/10.1017/S0033291713002031
51. Wang, Y.; Xu, C.; Cao, X.; Gao, Q.; Li, J.; Liu, Z.; Sun, N.; Ren, Y.; Zhang, K. Effects of an antidepressant on neural correlates of emotional processing in patients with major depression. Neurosci. Lett., 2012, 527, 55-9. http://dx.doi.org/10.1016/j.neulet.2012.08.034
52. Jiang, W.; Yin, Z.; Pang, Y.; Wu, F.; Kong, L.; Xu, K. Brain functional changes in facial expression recognition in patients with major depressive disorder before and after antidepressant treatment: A functional magnetic resonance imaging study. Neural Regen. Res., 2012, 7, 1151-7.
53. Rive, M.M.; van Rooijen, G.; Veltman, D.J.; Phillips, M.L.; Schene, A.H.; Ruhe, H.G. Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies. Neurosci. Biobehav. Rev., 2013, 37, 2529-53. http://dx.doi.org/10.1016/j.neubiorev.2013.07.018
54. Leppanen, J.M.; Nelson, C.A. The development and neural bases of facial emotion recognition. Adv. Child. Dev. Behav., 2006, 34, 207-46. http://dx.doi.org/10.1016/S0065-2407(06)80008-X
55. Poulsen, C.; Luu, P.; Crane, S.M.; Quiring, J.; Tucker, D.M. Frontolimbic activity and cognitive bias in major depression. J. Abnorm. Psychol., 2009, 118, 494-506. http://dx.doi.org/10.1037/ a0015920
56. Herrington, J.D.; Taylor, J.M.; Grupe, D.W.; Curby, K.M.; Schultz, R.T. Bidirectional communication between amygdala and fusiform gyrus during facial recognition. Neuroimage, 2011, 56, 2348-55. http://dx.doi.org/10.1016/j.neuroimage.2011.03.072
57. Morris, J.S.; Friston, K.J.; Buchel, C.; Frith, C.D.; Young, A.W.; Calder, A.J.; Dolan, R.J. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain, 1998, 121 (Pt 1), 47-57. http://dx.doi.org/10.1093/brain/121.1.47
58. Fu, C.H.; Steiner, H.; Costafreda, S.G. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol. Dis., 2013, 52, 75-83. http://dx.doi.org/10.1016/j.nbd.2012.05.008
59. Furey, M.L.; Drevets, W.C.; Hoffman, E.M.; Frankel, E.; Speer, A.M.; Zarate, C.A., Jr. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry, 2013, 70, 280-90. http://dx.doi.org/10.1001/2013. jamapsychiatry.60
60. McGrath, C.L.; Kelley, M.E.; Holtzheimer, P.E.; Dunlop, B.W.; Craighead, W.E.; Franco, A.R.; Craddock, R.C.; Mayberg, H.S. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry, 2013, 70, 821-9. http://dx. doi.org/10.1001/jamapsychiatry.2013.143
61. Siegle, G.J.; Thompson, W.K.; Collier, A.; Berman, S.R.; Feldmiller, J.; Thase, M.E.; Friedman, E.S. Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch. Gen. Psychiat., 2012, 69, 913-24. http://dx. doi.org/10.1001/archgenpsychiatry.2012.65
62. Costafreda, S.G.; Chu, C.; Ashburner, J.; Fu, C.H. Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One, 2009, 4, e6353. http://dx.doi.org/10.1371/journal.pone. 0006353